Sign in
4

Changes in Ownership

Trevi Therapeutics, Inc. Filed Acc 0001209191-22-024323

Director acquired 948,948 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mathers Edward T · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-04-11 Grant or award : show line 1 in the form +948,948 $1.90 $1,803,001 948,948 I

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-04-11 Grant or award : show line 2 in the form Pre-Funded Warrants +3,000,000 $1.90 $5,697,000 3,000,000 I
Loading xslF345X03/doc4.xml…